Status:
COMPLETED
Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section
Lead Sponsor:
Fresenius Kabi
Conditions:
Hypotension
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal hypotension in women undergoing spinal anesthesia for cesarean section
Detailed Description
Intravenous fluid administration prior to spinal anesthesia for cesarean section is an established part of anesthetic practice for the prevention of maternal hypotension. Systematic reviews of clinica...
Eligibility Criteria
Inclusion
- elective cesarean section applying spinal anesthesia
- ≥ week 37 of gestation
- Singleton pregnancy
Exclusion
- Suspicion of any hypertensive disease
- Parturient in labor
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00694343
Start Date
June 1 2008
End Date
June 1 2010
Last Update
May 31 2012
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont Ferrand - Hotel Dieu, Service Anesthesie-Reanimation
Clermont-Ferrand, France, 63003
2
Höpital Louis-Mourier - Service d'Anesthesie
Colombes, France, 92701
3
Département d'Anesthésie-Réanimation - Centre Hospitalo-Universitaire de Bicêtre
Le Kremlin-Bicêtre, France, 94275
4
Hopital Jeanne de Flandre, CHU
Lille, France, 59037